Profile: Monobind Inc. offers laboratory diagnostic products. Our product categories are immunoassays, R&D immunoassay tools, instruments and biomaterials. Our product list comprises of streptavidin coated plates, antibody coated plates, conjugate stabilizers, and immunoassays such as diabetes, cancer markers, cardiac markers & steroids. We offers 96-well plates, coated with streptavidin-biotin for use in manual or automated systems. These plates provide a framework for any type of immunoassay research work. Eldex 3.8 is our ready-to-use, stand-alone instrument providing quantitative results for immunological or biochemical parameters. This analyzer is an automated tool for small to mid-size clinical laboratories.
The company was founded in 1978, has revenues of USD 1-5 Million, has ~50 employees and is ISO 9001:2000, ISO 13485:2003 certified.
FDA Registration Number: 2020726
46 Products/Services (Click for related suppliers)
|
• 17-Hydroxyprogesterone Radioimmunoassay Test (FDA Code: JLX / 862.1395) A 17-hydroxyprogesterone test system is a device intended to measure 17-hydroxyprogesterone (a steroid) in plasma and serum. Measurements of 17-hydroxyprogesterone are used in the diagnosis and treatment of various disorders of the adrenal glands or the ovaries. |
• Alpha Fetoprotein L3 Subfraction (Afp-L3%) Test For Hepatocellular Carcinoma Risk Assessment (FDA Code: NSF / 866.6030) |
• C Peptides of Proinsulin Radioimmunoassay Test (FDA Code: JKD / 862.1135) A C-peptides of proinsulin test system is a device intended to measure C-peptides of proinsulin levels in serum, plasma, and urine. Measurements of C-peptides of proinsulin are used in the diagnosis and treatment of patients with abnormal insulin secretion, including diabetes mellitus. |
• C-Reactive Protein Test System (FDA Code: DCN / 866.5270) A C-reactive protein immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the C-reactive protein in serum and other body fluids. Measurement of C-reactive protein aids in evaluation of the amount of injury to body tissues. |
• Calibrators |
• Campylobacter Pylori (FDA Code: LYR / 866.3110) |
• Cancer Marker Assays |
• Carbohydrate Antigen (Ca19-9) Test System For Monitoring And Management Of Pancreatic Cancer (FDA Code: NIG / 866.6010) A tumor-associated antigen immunological test system is a device that consists of reagents used to qualitatively or quantitatively measure, by immunochemical techniques, tumor-associated antigens in serum, plasma, urine, or other body fluids. This device is intended as an aid in monitoring patients for disease progress or response to therapy or for the detection of recurrent or residual disease. |
• Carcinoembryonic Antigen Test System (FDA Code: DHX / 866.6010) |
• Cardiac Markers |
• Cortisol Radioimmunoassay Test (FDA Code: CGR / 862.1205) A cortisol (hydrocortisone and hydroxycorticosterone) test system is a device intended to measure the cortisol hormones secreted by the adrenal gland in plasma and urine. Measurements of cortisol are used in the diagnosis and treatment of disorders of the adrenal gland. |
• Digoxin Enzyme Immunoassay Test (FDA Code: KXT / 862.3320) A digoxin test system is a device intended to measure digoxin, a cardiovascular drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to ensure appropriate therapy. |
• ELISA Chemistry Analyzer |
• Estradiol Radioimmunoassay Test (FDA Code: CHP / 862.1260) An estradiol test system is a device intended to measure estradiol, an estrogenic steroid, in plasma. Estradiol measurements are used in the diagnosis and treatment of various hormonal sexual disorders and in assessing placental function in complicated pregnancy. |
• Estriol Radioimmunoassay Test (FDA Code: CGI / 862.1265) An estriol test system is a device intended to measure estriol, an estrogenic steroid, in plasma, serum, and urine of pregnant females. Estriol measurements are used in the diagnosis and treatment of fetoplacental distress in certain cases of high-risk pregnancy. |
• Ferritin Radioimmunoassay Test (FDA Code: JMG / 866.5340) A ferritin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the ferritin (an iron-storing protein) in serum and other body fluids. Measurements of ferritin aid in the diagnosis of diseases affecting iron metabolism, such as hemochromatosis (iron overload) and iron deficiency amemia. |
• Follicle Stimulating Hormone Radioimmunoassay (FDA Code: CGJ / 862.1300) A follicle-stimulating hormone test system is a device intended to measure follicle-stimulating hormone (FSH) in plasma, serum, and urine. FSH measurements are used in the diagnosis and treatment of pituitary gland and gonadal disorders. |
• Free Thyroxine Radioimmunoassay (FDA Code: CEC / 862.1695) A free thyroxine test system is a device intended to measure free (not protein bound) thyroxine (thyroid hormone) in serum or plasma. Levels of free thyroxine in plasma are thought to reflect the amount of thyroxine hormone available to the cells and may therefore determine the clinical metabolic status of thyroxine. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases. |
• Hcg Test kits |
• Human Chorionic Gonadotropin Radioimmunoassay (FDA Code: JHI / 862.1155) A human chorionic gonadotropin (HCG) test system is a device intended for the early detection of pregnancy is intended to measure HCG, a placental hormone, in plasma or urine. |
• Human Growth Hormone Radioimmunoassay (FDA Code: CFL / 862.1370) A human growth hormone test system is a device intended to measure the levels of human growth hormone in plasma. Human growth hormone measurements are used in the diagnosis and treatment of disorders involving the anterior lobe of the pituitary gland. |
• IgE Control (FDA Code: DGC / 866.5510) An immunoglobulins A, G, M, D, and E immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the immunoglobulins A, G, M, D, an E (serum antibodies) in serum. Measurement of these immunoglobulins aids in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents. |
• Immunoassay Chemistry Tests for Infectious Disease |
• Immunoassay Chemistry Tests for Thyroid |
• Immunoassays |
• Immunoreactive Insulin Radioimmunoassay Test (FDA Code: CFP / 862.1405) An immunoreactive insulin test system is a device intended to measure immunoreactive insulin in serum and plasma. Immunoreactive insulin measurements are used in the diagnosis and treatment of various carbohydrate metabolism disorders, including diabetes mellitus, and hypoglycemia. |
• Infectious Diseases Assays |
• Luteinizing Hormone Radioimmunoassay (FDA Code: CEP / 862.1485) A luteinizing hormone test system is a device intended to measure luteinizing hormone in serum and urine. Luteinizing hormone measurements are used in the diagnosis and treatment of gonadal dysfunction. |
• Myoglobin Immunoassay Biosensor (FDA Code: MVE / 866.5680) A myoglobin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the myoglobin (an oxygen storage protein found in muscle) in serum and other body fluids. Measurement of myoglobin aids in the rapid diagnosis of heart or renal disease. |
• Ovarian Tumor-Associated Antigen(Ca 125) Test (FDA Code: LTK / 866.6010) |
• Progesterone Radioimmunoassay Test (FDA Code: JLS / 862.1620) A progesterone test system is a device intended to measure progesterone (a female hormone) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of disorders of the ovaries or placenta. |
• Prolactin Radioimmunoassay (FDA Code: CFT / 862.1625) A prolactin (lactogen) test system is a device intended to measure the anterior pituitary polypeptide hormone prolactin in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of disorders of the anterior pituitary gland or of the hypothalamus portion of the brain. |
• Prostate-Specific Antigen for Management of Prostate Cancers (FDA Code: LTJ / 866.6010) |
• Radioimmunoassay for Dehydroepiandrosterone Sulfate (FDA Code: JKC / 862.1245) A dehydroepiandrosterone (free and sulfate) test system is a device intended to measure dehydroepiandrosterone (DHEA) and its sulfate in urine, serum, plasma, and amniotic fluid. Dehydroepiandrosterone measurements are used in the diagnosis and treatment of DHEA-secreting adrenal carcinomas. |
• Radioimmunoassay for Immunoglobulin G, A, M (FDA Code: CFQ / 866.5510) |
• Serum Human Chorionic Gonadotropin Test (FDA Code: DHA / 862.1155) |
• Testosterones and Dihydrotestosterone Radioimmunoassay (FDA Code: CDZ / 862.1680) A testosterone test system is a device intended to measure testosterone (a male sex hormone) in serum, plasma, and urine. Measurement of testosterone are used in the diagnosis and treatment of disorders involving the male sex hormones (androgens), including primary and secondary hypogonadism, delayed or precocious puberty, impotence in males and, in females hirsutism (excessive hair) and virilization (masculinization) due to tumors, polycystic ovaries, and adrenogenital syndromes. |
• Thyroglobulin (FDA Code: DDC / 866.5870) A thyroid autoantibody immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the thyroid autoantibodies (antibodies produced against the body's own tissues). Measurement of thyroid autoantibodies may aid in the diagnosis of certain thyroid disorders, such as Hashimoto's disease (chronic lymphocytic thyroiditis), nontoxic goiter (enlargement of thyroid gland), Grave's disease (enlargement of the thyroid gland with protrusion of the eyeballs), and cancer of the thyroid. |
• Thyroglobulin Autoantibody Immunochemical (FDA Code: JNL / 866.5870) |
• Thyroid Stimulating Hormone Radioimmunoassay (FDA Code: JLW / 862.1690) A thyroid stimulating hormone test system is a device intended to measure thyroid stimulating hormone, also known as thyrotrophin and thyrotrophic hormone, in serum and plasma. Measurements of thyroid stimulating hormone produced by the anterior pituitary are used in the diagnosis of thyroid or pituitary disorders. |
• Thyroxine Binding Globulin Radioimmunoassay (FDA Code: CEE / 862.1685) A thyroxine-binding globulin test system is a device intended to measure thyroxine (thyroid)-binding globulin (TBG), a plasma protein which binds thyroxine, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases. |
• Total Thyroxine Non-Radiolabeled Enzyme Immunoassay (FDA Code: KLI / 862.1700) A total thyroxine test system is a device intended to measure total (free and protein bound) thyroxine (thyroid hormone) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases. |
• Total Triiodothyronine Radioimmunoassay (FDA Code: CDP / 862.1710) A total triiodothyronine test system is a device intended to measure the hormone triiodothyronine in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases such as hyperthyroidism. |
• Triiodothyronine Uptake Radioassay (FDA Code: KHQ / 862.1715) A triiodothyronine uptake test system is a device intended to measure the total amount of binding sites available for binding thyroid hormone on the thyroxine-binding proteins, thyroid-binding globulin, thyroxine-binding prealbumin, and albumin of serum and plasma. The device provides an indirect measurement of thyrkoxine levels in serum and plasma. Measurements of triiodothyronine uptake are used in the diagnosis and treatment of thyroid disorders. |
• Tumor Antigen Immunological Test System (FDA Code: MOI / 866.6010) |
• Washer/Sterilizer |